Browsing Tag
Harvard Medical School
10 posts
Humacyte’s dialysis bet gains momentum, but $0.71 stock still reflects major execution risk
HUMA jumps 22% as peer-reviewed ATEV Phase 3 data strengthen Humacyte’s planned FDA filing for a potentially much larger dialysis market.
Doximity (NYSE: DOCS) shares surge 55% as clinical AI adoption transforms the earnings story despite weaker profit
Doximity shares surged after fiscal Q1 revenue beat expectations and clinical AI engagement accelerated, even though earnings, free cash flow and EBITDA declined. The reaction suggests investors are beginning to value Doximity less as a physician advertising platform and more as a potential clinical AI infrastructure company.
Sun Pharmaceutical (NSE: SUNPHARMA) launches UNLOXCYT in U.S. for aCSCC
Sun Pharma's UNLOXCYT is now available in the U.S. for advanced CSCC. Find out how this checkpoint inhibitor could reshape skin cancer treatment today.
Dr. Takuma Hayashi identifies LMP2 deficiency as key to uterine LMS, ushering in new era of precision cancer treatment
Dr. Takuma Hayashi’s molecular discovery of LMP2 deficiency in uterine LMS marks a breakthrough in precision oncology, unlocking new diagnostic and treatment pathways.
MIT star and NCAA Woman of the Year dies in devastating plane crash with entire family
Former NCAA Woman of the Year Karenna Groff, her partner, and her family were killed in a plane crash en route to celebrate her birthday. Learn more.
Apple’s latest health project might just predict your future health risks
Apple has officially launched the Apple Health Study, marking a significant step towards redefining how technology can be…
Thermo Fisher Scientific launches global CorEvitas adolescent alopecia areata registry to advance real-world research
Thermo Fisher Scientific Inc., a global leader in serving science, has unveiled the international CorEvitas adolescent alopecia areata…
CSL Limited’s AEGIS-II trial of CSL112 fails to meet primary endpoint in heart attack patients
CSL Limited (ASX:CSL; USOTC:CSLLY), a renowned global biotechnology leader, disclosed the top-line outcomes from its eagerly anticipated Phase…
Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal…
Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment
Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA)…